HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Chen Selected Research

Moyamoya disease 3

8/2019[The application of hybrid operation suite in the management of cerebral and spinal vascular diseases and intracranial hypervascular tumors].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Chen Research Topics

Disease

176Neoplasms (Cancer)
05/2022 - 01/2000
41Infections
04/2022 - 11/2000
38Inflammation (Inflammations)
04/2022 - 01/2000
34Neoplasm Metastasis (Metastasis)
05/2022 - 01/2000
21Prostatic Neoplasms (Prostate Cancer)
07/2019 - 04/2000
20Stomach Neoplasms (Stomach Cancer)
02/2022 - 10/2012
20Type 2 Diabetes Mellitus (MODY)
11/2021 - 08/2002
20Breast Neoplasms (Breast Cancer)
01/2021 - 04/2000
18Carcinoma (Carcinomatosis)
10/2020 - 06/2000
17Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2001
17Carcinogenesis
03/2020 - 05/2000
16Insulin Resistance
03/2022 - 05/2001
15Fibrosis (Cirrhosis)
05/2022 - 01/2000
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2002
15Lung Neoplasms (Lung Cancer)
01/2020 - 03/2000
14Wounds and Injuries (Trauma)
04/2022 - 02/2001
14Pain (Aches)
11/2021 - 04/2000
13Hypertension (High Blood Pressure)
01/2022 - 05/2000
13Body Weight (Weight, Body)
03/2021 - 06/2001
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2013
13Leukemia
05/2019 - 02/2000
11Hypoxia (Hypoxemia)
12/2018 - 07/2001
10Adenocarcinoma
05/2022 - 04/2001
10Diabetes Mellitus
05/2022 - 05/2006
10Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 01/2000
10Hemorrhage
02/2022 - 09/2011
9Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2010
9Chronic Hepatitis B
11/2021 - 12/2001
9Necrosis
01/2021 - 04/2000
8Osteoarthritis
01/2022 - 04/2001
8Colonic Neoplasms (Colon Cancer)
04/2021 - 06/2000
8Rheumatoid Arthritis
04/2020 - 11/2007
8Nasopharyngeal Carcinoma
01/2019 - 12/2005
7Hypersensitivity (Allergy)
07/2022 - 09/2000
7Pneumonia (Pneumonitis)
05/2022 - 07/2014
7Flatulence
05/2022 - 02/2017
7Osteoporosis
05/2022 - 11/2009
7Myocardial Infarction
02/2022 - 05/2000
7Obesity
01/2022 - 06/2012
7Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 02/2009
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2020 - 03/2000
7Ischemia
07/2018 - 06/2001
6Mouth Neoplasms (Oral Cancer)
01/2022 - 06/2013
6Osteosarcoma (Osteogenic Sarcoma)
10/2021 - 09/2000
6Squamous Cell Carcinoma of Head and Neck
09/2021 - 01/2015
6Glioma (Gliomas)
12/2020 - 11/2001
6Lymphatic Metastasis
11/2020 - 06/2000
6Residual Neoplasm
05/2020 - 01/2013
6Thrombosis (Thrombus)
11/2019 - 06/2003
6Chronic Obstructive Pulmonary Disease (COPD)
10/2019 - 09/2010
6Atherosclerosis
01/2018 - 09/2000

Drug/Important Bio-Agent (IBA)

78Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2000
33Messenger RNA (mRNA)IBA
11/2020 - 01/2000
28CytokinesIBA
01/2022 - 11/2000
26Biomarkers (Surrogate Marker)IBA
03/2020 - 03/2000
21Glucose (Dextrose)FDA LinkGeneric
05/2022 - 05/2000
21MicroRNAs (MicroRNA)IBA
10/2021 - 01/2012
20Biological ProductsIBA
06/2021 - 01/2000
16DNA (Deoxyribonucleic Acid)IBA
12/2020 - 02/2000
15Pharmaceutical PreparationsIBA
06/2020 - 01/2001
14AntigensIBA
01/2022 - 03/2000
13Insulin (Novolin)FDA Link
03/2022 - 08/2002
12Long Noncoding RNAIBA
12/2020 - 01/2015
12Interleukin-6 (Interleukin 6)IBA
03/2020 - 12/2004
12Interleukin-2 (IL2)IBA
01/2020 - 04/2000
11EnzymesIBA
01/2022 - 01/2000
10Therapeutic UsesIBA
02/2021 - 10/2012
10InterferonsIBA
12/2020 - 04/2002
10RNA (Ribonucleic Acid)IBA
01/2020 - 03/2000
9Blood Glucose (Blood Sugar)IBA
11/2021 - 08/2002
9LipidsIBA
01/2021 - 08/2002
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 04/2000
9ErbB Receptors (EGF Receptor)IBA
11/2017 - 06/2000
9Small Interfering RNA (siRNA)IBA
11/2017 - 06/2006
8Anti-Bacterial Agents (Antibiotics)IBA
07/2022 - 12/2010
8CreatinineIBA
05/2021 - 05/2007
8Hormones (Hormone)IBA
04/2020 - 04/2000
8LigandsIBA
01/2019 - 08/2000
8Triglycerides (Triacylglycerol)IBA
10/2016 - 05/2001
7GlucocorticoidsIBA
05/2022 - 11/2009
7Cisplatin (Platino)FDA LinkGeneric
07/2021 - 07/2008
7Immunoglobulin G (IgG)IBA
01/2013 - 08/2000
6CholesterolIBA
05/2022 - 05/2001
6VaccinesIBA
01/2022 - 02/2014
6Interleukin-10 (Interleukin 10)IBA
11/2021 - 01/2001
6AlbuminsIBA
05/2021 - 09/2010
6InterleukinsIBA
02/2021 - 12/2004
6Indicators and Reagents (Reagents)IBA
04/2020 - 10/2001
6AntibodiesIBA
10/2019 - 09/2000

Therapy/Procedure

79Therapeutics
05/2022 - 04/2000
22Drug Therapy (Chemotherapy)
01/2022 - 10/2001
19Radiotherapy
02/2020 - 01/2004
12Length of Stay
05/2022 - 02/2017
12Transplantation
04/2022 - 01/2000
11Aftercare (After-Treatment)
12/2021 - 11/2000
7Stents
05/2022 - 03/2000
7Gastrectomy
05/2022 - 03/2016
7Lasers (Laser)
05/2019 - 12/2000
6Immunotherapy
12/2021 - 07/2000
6Lymph Node Excision (Lymph Node Dissection)
02/2021 - 05/2000